Related Experiment Video
Updated: Mar 30, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
[Orthopaedic implant-associated infections: Update of antimicrobial therapy]
1Interdisziplinäre Einheit für Orthopädische Infektionen, Medizinische Universitätsklinik Liestal, Kantonsspital Baselland, Rheinstrasse 26, 4410, Liestal, Schweiz. Werner.zimmerli@unibas.ch.
Abstract:
In infections related to prosthetic joints and internal fixation devices, microorganisms adhere as biofim on the surface of the implant. Biofilms are not only resistant to phagocytosis, but also to most antimicrobial agents. Therefore, spontaneous cure does never occur, and antibiotics have to be given for several months. According to traditional concepts, removal of all foreign material was considered as prerequisite for cure. Yet, during the last decades, it has been shown that staphylococcal biofilms can be eliminated by rifampin combination therapy, and Gram-negative biofilms by fluoroquinolones. However, reliable biofilm elimination is only possible, if the duration of infection does not exceed 3-4 weeks. Correct total duration of the antimicrobial therapy has never been tested in a controlled trial. Currently, treatment duration is 3 (hip prosthesis) and 6 (knee prosthesis) months in patients undergoing débridement with implant retention, one-stage exchange, and two-stage exchange with a short interval of 2-3 weeks. According to a recent observational trial, a treatment duration of 2 and 3 months, respectively, is equivalent to the longer duration in patients undergoing débridement and implant retention. The optimal surgical therapy should be chosen according to a rational algorithm. It is crucial choosing the optimal surgical intervention from the beginning, because the final functional success depends on the cure by the first attempt.
Insights
Treating implant-associated infections requires long antibiotic courses. Shorter antibiotic durations (2-3 months) may be effective for biofilm elimination, especially with early intervention and appropriate surgical strategies.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Biomaterials Science
Context:
- Implant-associated infections involve biofilms resistant to antibiotics and host defenses.
- Traditional treatment often necessitates foreign material removal.
- Emerging therapies show promise for biofilm eradication without implant removal.
Purpose:
- To review current strategies for managing implant-associated infections.
- To evaluate the efficacy of different antibiotic regimens and treatment durations.
- To emphasize the importance of timely and appropriate surgical intervention.
Summary:
- Microorganisms form biofilms on prosthetic joints and fixation devices, leading to persistent infections.
- While historically requiring implant removal, certain antibiotic combinations (e.g., rifampin, fluoroquinolones) can eliminate biofilms if infection is diagnosed early (within 3-4 weeks).
- Current treatment durations vary (3-6 months), but recent trials suggest shorter courses (2-3 months) may be equivalent for specific procedures like débridement with implant retention.
Impact:
- Optimizing treatment duration can reduce antibiotic exposure and associated side effects.
- Establishing rational algorithms for surgical intervention improves functional outcomes.
- Early and effective management is critical for successful cure and patient recovery.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis III: Medical Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis IV: Nursing Management
Bacterial Signaling

